Press release
Peptide Based Metabolic Disorders Therapeutics Market Forecast will Surpass US$ 8 Bn by 2022
The global peptide based metabolic disorders therapeutics market is anticipated to show a value more than US$ 8 Bn and expected to grow at a robust rate during the period of forecast.
5 Forecast Highlights on Global Peptide Based Metabolic Disorders Therapeutics Market
Request For Report Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=187
North America expected to grow at the highest CAGR to reflect a growth rate of 10.6% during the period of forecast as well as dominate the global market in terms of market share by revenue, as of 2017. It can be said that this trend would be followed, considering the technological developments, and the higher investments in the healthcare industry that this segment portrays, and retain its dominant position by the end of 2022, at least
Asia-Pacific excluding Japan (APEJ) region also anticipated to grow at a similar growth rate as of North America region, yet does not portray high market share by revenue. The market share by revenue of APEJ is less than one third than that of North America region and less than half of the market revenue share of the Europe region
Liraglutide segment by drug class is expected to grow at a robust rate during the period of forecast and dominates the market by drug class in terms of market share by revenue as of 2017. However, the growth rate of this segment is comparatively low than that of the other two segments by drug class
Request For Discount: https://www.factmr.com/connectus/sample?flag=D&rep_id=187
The others segment and the exenatide segment by drug class are poised to grow at a similar growth rate throughout the period of forecast, 2017 to 2022. However, the exenatide segment experiences a higher market share by revenue than the other segment. Both these segments are expected to gain BPS by the end of 2022, exenatide segment having an upper hand with respect to BPS aspect as well
Hospital pharmacies segment reflect higher market share by revenue and a well off growth rate during the period of forecast. But it is bound to lose BPS by the end of 2022. The retail pharmacies segment stands second as far as market share by revenue is concerned, and it has a higher growth rate than the hospital pharmacies segment. The online pharmacies segment is the fastest growing segment by distribution channel, and is expected to register a CAGR of 11.8% during the period of forecast. Yet, this segment has low market share by revenue as compared to the other two segments. It is also anticipated that the online pharmacies segment will gain a huge BPs by the end of 2022
The report has also profiled leading players in the global market for peptide based metabolic disorders therapeutics, which would remain active through 2022. These include companies like Bachem Holding AG, AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., PolyPeptide Group, Novo Nordisk A/S, Merck & Co., Inc., Ipsen S.A, Eli Lilly and Company, and CordenPharma International.
Browse Full Report: https://www.factmr.com/report/187/peptide-based-metabolic-disorders-therapeutics-market
ABOUT US:
Fact.MR is focused on offering transformative intelligence that inspires breakthroughs and innovation. We believe that the right decisions at the opportune time are integral to achieve extraordinary success. We are here to help you with your strategic decision making.
CONTACT:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Phone: +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Metabolic Disorders Therapeutics Market Forecast will Surpass US$ 8 Bn by 2022 here
News-ID: 686042 • Views: …
More Releases from Fact.MR
Citrus Fiber Market is Expanding at a 5.7% of CAGR by 2034 | Fact.MR Report
The global Citrus Fiber Market is projected to experience substantial growth over the next decade, driven by rising demand for clean-label ingredients, functional food components, and sustainable fiber sources.
Market analysts estimate that the market, valued at approximately USD 350 million in 2025, is expected to reach around USD 720 million by 2035, expanding at a compound annual growth rate (CAGR) of about 7.5% during the forecast period.
Get Access of…
Gluten-Free Food Market is Predicted to Grow to USD 6.5 Billion in 2026 and USD …
The global gluten-free food market is entering a phase of mainstream consolidation, projected to grow from a valuation of USD 7.4 billion in 2026 to approximately USD 15.2 billion by 2036. This represents a steady compound annual growth rate (CAGR) of 7.5% over the ten-year forecast period.
While initially driven by medical necessity for celiac disease patients, the market is now being propelled by "lifestyle consumers" who perceive gluten-free products…
Electronic Speed Controller for Drones and UAVs Market is Valued USD 448.0 milli …
The global electronic speed controller (ESC) for drones and UAVs market is experiencing a rapid technological surge, projected to grow from a valuation of USD 1.8 billion in 2026 to approximately USD 5.1 billion by 2036. This represents a strong compound annual growth rate (CAGR) of 11.0% over the ten-year forecast period.
The market is being propelled by the proliferation of long-endurance commercial drones, the militarization of small FPV (First…
Car Tail Light Mold Market is Hoped-for USD 3.6 billion by 2036 | Fact.MR Report
The global car tail light mold market is navigating a high-design era, projected to grow from a valuation of USD 1.4 billion in 2026 to approximately USD 2.6 billion by 2036. This represents a compound annual growth rate (CAGR) of 6.4% over the forecast period.
The market is being fundamentally reshaped by the transition from simple bulbs to complex LED and OLED signatures, requiring high-precision multi-color and multi-material injection molding…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
